Daily Round Up 4/20/16: OPK, VEEV, HCFB, OMAM

by: InsiderInsights


Tables of the top insider purchases and sales filed with the SEC on 4/20/16, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are relayed to clarify significance.

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance, it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company's or insider's full insider history.

Educational note from InsiderInsights:
Insider filing volumes are at a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily Round Up articles (particularly the purchases) will likely be lower than usual until early May.

On Today's Tables:

Insider trades were rated Significant at :

  • Veeva Systems (NYSE:VEEV), and;
  • OPKO Health (NYSE:OPK).

Insider trades were rated Nearly Significant at:

Insider trades were considered Insignificant at:

  • Wound Mgt Technologies (OTCQB:WNDM);
  • Labor Smart (OTCPK:LTNC);
  • Nuveen Global Equity Income Fund (NYSE:JGV);
  • Nuveen Ohio Quality Income Municipal Fund (NYSE:NUO);
  • Nuveen MLP TR Fd (NYSE:JMF);
  • Ares DC Alloc Fd (NYSE:ARDC);
  • Marcus & Millichap (NYSE:MMI);
  • Alphabet (NASDAQ:GOOG);
  • Facebook (NASDAQ:FB);
  • Emergent Bio (NYSE:EBS);
  • (NYSE:CRM);
  • Broadsoft (NASDAQ:BSFT), and;

There is a Conflicted Insider Signal (both purchases & sales) at:

  • FibroGen (NASDAQ:FGEN).

There is an IPO or Known Corporate Action at:

  • BATS Global Markets (Pending:BATS).

It's difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.

Insider Purchases

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Concannon Christopher R CEO,DIR BATS Global Markets BATS JB* $475,000
2 Stuckert James W DIR,BO Wound Mgt. Technologies WNDM JB* $150,010
3 McElveen William Jack Jr CCO HCSB Financial HCFB JB* $125,000
4 Harkins Bryan VP BATS Global Markets BATS JB* $120,650
5 Frost Phillip Md CEO,CB,BO OPKO Health OPK B $81,373
6 Schadel Christopher Ryan CEO,DIR,BO Labor Smart LTNC B $77,883
7 Schneider William DIR Nuveen Ohio Qu Inc Muni Fd NUO B $49,924
8 Schneider William TT Nuveen MLP TR Fd JMF B $49,764
9 Reiss M Freddie DIR Ares DC Alloc Fd ARDC B $33,488
10 Bulldog Investors BO Nuveen Gl Eq Inc Fd JGV B $31,686
Click to enlarge

Source: | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales

#: Filer Name Insider Titles Company Name Ticker Trans
Dollar Value
1 Koum Jan DIR Facebook FB AS $157,894,496
2 Armenante Mark BO Veeva Systems VEEV AS $3,839,774
3 Pichai Sundar CEO Alphabet GOOG AS $3,039,609
4 Benioff Marc CB,CEO CRM AS $2,868,534
5 Berman Gene A VP Marcus & Millichap MMI AS $1,355,104
6 Puhy Dorothy E DIR ABIOMED ABMD AS $1,000,000
7 El Hibri Fuad CB,DIR,BO Emergent Bio EBS AS $842,036
8 Neff Thomas B CEO,DIR,BO FibroGen FGEN AS $539,460
9 Bain Peter L CEO,DIR OM Asset Mgt. OMAM AS $402,887
10 Tessler Michael CEO,DIR Broadsoft BSFT AS $390,761
Click to enlarge | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

If you're interested in the insider history of a stock not shown here, you can search by ticker.

Did you miss our Previous Daily Round Up?

Disclosure: I am/we are long OPK.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.